182 related articles for article (PubMed ID: 20388114)
1. PET with non-standard nuclides.
Hao G; Singh AN; Liu W; Sun X
Curr Top Med Chem; 2010; 10(11):1096-112. PubMed ID: 20388114
[TBL] [Abstract][Full Text] [Related]
2. Unconventional nuclides for radiopharmaceuticals.
Holland JP; Williamson MJ; Lewis JS
Mol Imaging; 2010 Feb; 9(1):1-20. PubMed ID: 20128994
[TBL] [Abstract][Full Text] [Related]
3. Image quality with non-standard nuclides in PET.
Laforest R; Liu X
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):151-8. PubMed ID: 18043539
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in copper radiopharmaceuticals.
Hao G; Singh AN; Oz OK; Sun X
Curr Radiopharm; 2011 Apr; 4(2):109-21. PubMed ID: 22191650
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.
Welch MJ; Laforest R; Lewis JS
Ernst Schering Res Found Workshop; 2007; (62):159-81. PubMed ID: 17172155
[TBL] [Abstract][Full Text] [Related]
7. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
8. Simulation of triple coincidences in PET.
Cal-González J; Lage E; Herranz E; Vicente E; Udias JM; Moore SC; Park MA; Dave SR; Parot V; Herraiz JL
Phys Med Biol; 2015 Jan; 60(1):117-36. PubMed ID: 25479147
[TBL] [Abstract][Full Text] [Related]
9. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
[TBL] [Abstract][Full Text] [Related]
10. Quantitative small animal PET imaging with nonconventional nuclides.
Liu X; Laforest R
Nucl Med Biol; 2009 Jul; 36(5):551-9. PubMed ID: 19520296
[TBL] [Abstract][Full Text] [Related]
11. Computer-Assisted Design of Peptide-Based Radiotracers.
Patamia V; Zagni C; Brullo I; Saccullo E; Coco A; Floresta G; Rescifina A
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047831
[TBL] [Abstract][Full Text] [Related]
12. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceutical chemistry for positron emission tomography.
Li Z; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
[TBL] [Abstract][Full Text] [Related]
14. The search for consistency in the manufacture of PET radiopharmaceuticals.
Finn RD
Ann Nucl Med; 1999 Dec; 13(6):379-82. PubMed ID: 10656270
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical chemistry with iodine-124: a non-standard radiohalogen for positron emission tomography.
Chacko AM; Divgi CR
Med Chem; 2011 Sep; 7(5):395-412. PubMed ID: 21711220
[TBL] [Abstract][Full Text] [Related]
16. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
[TBL] [Abstract][Full Text] [Related]
17. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
18. Decay data and production yields of some non-standard positron emitters used in PET.
Qaim SM
Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):111-20. PubMed ID: 18174879
[TBL] [Abstract][Full Text] [Related]
19. Development of radiodetection systems towards miniaturised quality control of PET and SPECT radiopharmaceuticals.
Taggart MP; Tarn MD; Esfahani MM; Schofield DM; Brown NJ; Archibald SJ; Deakin T; Pamme N; Thompson LF
Lab Chip; 2016 Apr; 16(9):1605-16. PubMed ID: 27044712
[TBL] [Abstract][Full Text] [Related]
20. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
Chua S; Gnanasegaran G; Cook GJ
Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]